Regulatory Structuring for Investors, Pharmaceutical Companies and Private Clinics

Healthcare investment in Serbia can be highly attractive. Demand is rising. The market is differentiating. Private healthcare is expanding. Pharmaceutical distribution is evolving.

However, Healthcare Law in Serbia is structured, procedural, and strictly supervised.

Licensing is not a formality. Registration is not administrative. Pricing approval is not automatic. Regulatory compliance is not optional.

In Serbia, healthcare operates within a tightly regulated legal framework governed by the Law on Healthcare, the Law on Medicines and Medical Devices, and oversight by the Ministry of Health and ALIMS.

If regulatory structuring is weak, investment risk increases. Delays occur. Market entry slows. Capital becomes exposed.

This page explains how Healthcare Law in Serbia functions from an investor’s perspective — focusing on licensing, pharmaceutical registration, medical device compliance, pricing approval, and strategic regulatory positioning.

Why Healthcare Investment in Serbia Requires Legal Structuring

Healthcare is not an ordinary commercial sector.

Authorities such as:

• Ministry of Health

• ALIMS (Medicines and Medical Devices Agency of Serbia)

• RFZO (National Health Insurance Fund)

apply formal procedural review.

In practice, this means:

• Market entry requires prior regulatory planning

• Pharmaceutical and medical device registration must follow structured documentation rules

• Maximum drug pricing must be formally approved

• Reimbursement listing requires pharmacoeconomic justification

• Inspections assess operational compliance, not intentions

Investors who structure legal compliance before operational launch avoid delays, rejected filings, and reputational exposure.

Who We Are

Stojković Attorneys is a Serbian law firm operating under the brand STATT.

Throughout this website, STATT refers to Stojković Attorneys and its regulatory advisory practice.

We advise healthcare investors, pharmaceutical companies, distributors, and private clinic founders on regulatory compliance, licensing strategy, and inspection preparedness in Serbia.

Our approach is structured, procedural, and aligned with Serbian healthcare legislation.

1. Establishing a Private Clinic in Serbia

Private healthcare projects require:

• Legal entity structuring

• Activity alignment with healthcare regulations

• Ministry of Health licensing

• Staffing compliance

• Premises and equipment compliance

• Internal operational protocols

Before investing in premises, branding, or equipment, investors must assess what Serbian healthcare law allows in the specific medical field.

We have prepared a detailed investor guide:

👉 Private Clinic in Serbia – A 2026 Guide for Investors
https://statt.rs/private-clinic-in-serbia-a-2026-guide-for-investors/

This guide explains the full licensing and inspection roadmap for private healthcare facilities.

2. Pharmaceutical Registration in Serbia (ALIMS)

Pharmaceutical products cannot enter the Serbian market without prior registration before ALIMS.

We assist with:

• Drug registration in Serbia

• EU CTD format alignment

• Preparation of registration dossiers

• Submission before ALIMS

• Monitoring procedure until marketing authorization issuance

• Renewal of marketing authorizations

• Variations and amendments

• Regulatory correspondence with authorities

Proper structuring at the submission stage significantly reduces procedural risk.

3. Medical Device Registration in Serbia

Medical devices must also be registered before ALIMS prior to distribution.

We advise on:

• Classification review

• Registration strategy

• Dossier preparation

• Renewal and amendments

• Compliance documentation

Foreign manufacturers must appoint a local representative and ensure regulatory alignment before market entry.

4. Drug Pricing and Reimbursement in Serbia

Wholesale drug prices must be approved.

Inclusion on the RFZO reimbursement list requires structured pharmacoeconomic documentation.

We assist with:

• Maximum wholesale price approval

• Preparation of pricing documentation

• Pharmacoeconomic analysis coordination

• RFZO submission and follow-up

Without proper pricing approval, commercial distribution cannot lawfully begin.

5. Healthcare Public Procurement and Distribution

Healthcare suppliers and distributors operate within public procurement frameworks.

We advise on:

• Participation in public procurement procedures

• Distribution agreements

• Sponsorship and donation agreements

• Contractual structuring with healthcare institutions

• Regulatory risk review

Contractual alignment is as important as regulatory compliance.

6. Vigilance, Compliance and Inspection Preparedness

Healthcare businesses must maintain internal compliance systems.

We support:

• Vigilance obligations

• Internal compliance protocols

• Documentation structuring

• Inspection preparedness

• Risk mitigation strategy

Healthcare inspections evaluate operational systems — not only documents.

Investors who build structured compliance early reduce long-term regulatory exposure.

Frequently Asked Questions – Healthcare Regulation in Serbia

Frequently Asked Questions – Healthcare Regulation in Serbia

How long does drug registration in Serbia take?

Drug registration in Serbia typically depends on dossier completeness, classification route, and regulatory review timelines before ALIMS (Agency for Medicines and Medical Devices of Serbia). Properly structured documentation in CTD format significantly reduces procedural delays.

Is EU drug registration valid in Serbia?

No. Serbia requires independent national registration before ALIMS, even if the drug has EU authorization. However, EU CTD documentation format is accepted and commonly used in Serbian regulatory submissions.

What is ALIMS in Serbia?

ALIMS (Agency for Medicines and Medical Devices of Serbia) is the national regulatory authority responsible for drug registration, medical device registration, pharmacovigilance, and licensing in Serbia.

Can a foreign investor establish a private clinic in Serbia?

Yes. Foreign investors may establish and fully own a private clinic in Serbia. However, they must obtain healthcare activity licensing, meet technical standards, and comply with Ministry of Health requirements before beginning operations.

For a full investor roadmap, see:
https://statt.rs/private-clinic-in-serbia-a-2026-guide-for-investors/

Is wholesale drug price approval mandatory in Serbia?

Yes. Before distribution, pharmaceutical products must receive formal wholesale price approval and, if applicable, inclusion on the national reimbursement list (RFZO).

Do foreign medical device manufacturers need a Serbian representative?

Yes. Foreign medical device manufacturers must appoint a local authorized representative in Serbia to ensure regulatory compliance and communication with ALIMS.

Is Serbian healthcare regulation aligned with EU standards?

Serbia’s pharmaceutical and medical device regulatory framework is largely harmonized with EU standards, including CTD documentation structure and pharmacovigilance obligations, although national procedures remain independent.

Strategic Consideration for Investors

Healthcare projects in Serbia succeed when:

• Legal structure precedes capital deployment

• Regulatory assessment precedes operational rollout

• Documentation precedes submission

• Compliance precedes inspection

Healthcare law in Serbia is procedural and predictable when properly structured.

It becomes risky only when improvised.

Contact

If you are considering:

• Establishing a private clinic in Serbia

• Registering pharmaceutical products

• Registering medical devices

• Structuring healthcare distribution

• Preparing for regulatory inspection

You may contact Stojković Attorneys (STATT):

+381 11 328 19 14
[email protected]